Anti-PD-1 checkpoint blockade improves the efficacy of a melphalan-based therapy in experimental melanoma

The efficacy of immunotherapy for in-transit metastases of melanoma: an analysis of randomized controlled trials

(2021) Roger Olofsson Bagge et al.   MELANOMA RESEARCH

ESMO consensus conference recommendations on the management of locoregional melanoma: the ESMO Guidelines Committee

(2020) O. Michielin et al.   ANNALS OF ONCOLOGY

High response rates for T-VEC in early metastatic melanoma (stage IIIB/C-IVM1a)

(2019) Viola Franke et al.   INTERNATIONAL JOURNAL OF CANCER

PD-1 blockade following isolated limb perfusion with vaccinia virus prevents local and distant relapse of soft-tissue sarcoma

(2019) Henry G Smith et al.   CLINICAL CANCER RESEARCH

Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial

(2019) Georgina V Long et al.   LANCET ONCOLOGY

Enhanced Therapeutic Efficacy of a Novel Oncolytic Herpes Simplex Virus Type 2 Encoding an Antibody Against Programmed Cell Death 1

(2019) Yujie Zhu et al.   Molecular Therapy-Oncolytics

Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different

(2018) Chung-Han Lee et al.   TRENDS IN IMMUNOLOGY

Talimogene Laherparepvec (TVEC) for the Treatment of Advanced Melanoma: A Single-Institution Experience

(2018) Matthew C. Perez et al.   ANNALS OF SURGICAL ONCOLOGY

Electrochemotherapy – Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration

(2018) Luca G. Campana et al.   EJSO

Minimally invasive isolated limb perfusion – technical details and initial outcome of a new treatment method for limb malignancies

(2018) Roger Olofsson Bagge et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer

(2018) Emmett V. Schmidt   Seminars in Immunopathology

Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma Patients

(2018) Junko Johansson et al.   Frontiers in Oncology

PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?

(2017) Sylvain Simon et al.   OncoImmunology

Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma

(2016) Lesly A. Dossett et al.   ANNALS OF SURGICAL ONCOLOGY

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

(2016) Robert H. I. Andtbacka et al.   ANNALS OF SURGICAL ONCOLOGY

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

(2016) Antoni Ribas et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antitumor Immunity Triggered by Melphalan Is Potentiated by Melanoma Cell Surface-Associated Calreticulin

(2015) A. M. Dudek-Peri  et al.   CANCER RESEARCH

Melphalan, Antimelanoma Immunity, and Inflammation--Letter

(2015) A. Martner et al.   CANCER RESEARCH

Alkylating Agent Melphalan Augments the Efficacy of Adoptive Immunotherapy Using Tumor-Specific CD4+T Cells

(2015) Xiaoyun Lu et al.   JOURNAL OF IMMUNOLOGY

Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma

(2014) John F. Thompson et al.   ANNALS OF SURGICAL ONCOLOGY

Isolated limb perfusion with melphalan for melanoma

(2014) Omgo E. Nieweg et al.   JOURNAL OF SURGICAL ONCOLOGY

In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates

(2014) C. Wang et al.   Cancer Immunology Research

Long-Term Outcome of Isolated Limb Perfusion in Advanced Soft Tissue Sarcoma of the Extremity

(2012) R. Olofsson et al.   ANNALS OF SURGICAL ONCOLOGY

PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer

(2012) C. Badoual et al.   CANCER RESEARCH

PD-1 and BTLA and CD8+T-cell “exhaustion” in cancer

(2012) Cara Haymaker et al.   OncoImmunology

20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters

(2011) Jan P. Deroose et al.   ANNALS OF SURGICAL ONCOLOGY

Chemoablation of metastatic melanoma using intralesional Rose Bengal

(2008) John F. Thompson et al.   MELANOMA RESEARCH